Australian Clinical Labs Limited (ACL.AX)
AUD 3.49
(-3.32%)
AUD 3.49
(-3.32%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 689.72 Million | 692.1 Million | 989.29 Million | 641.31 Million | 487.53 Million | 445.89 Million |
| Cost of Revenue | 442.36 Million | 126.08 Million | 207.59 Million | 119.58 Million | 402.48 Million | 313.89 Million |
| Gross Profit | 247.36 Million | 566.02 Million | 781.7 Million | 521.72 Million | 85.04 Million | 131.99 Million |
| Operating Expenses | 81.54 Million | 514.05 Million | 514.02 Million | 416.53 Million | 69.5 Million | 139.57 Million |
| Selling, General and Administrative Expenses | 87.19 Million | 297.39 Million | 314 Million | 249.68 Million | 69.5 Million | 139.57 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 201.82 Million | 10.02 Million | -1.07 Million | 3.35 Million | - | - |
| Cost and Expenses | 632.82 Million | 640.13 Million | 721.62 Million | 536.12 Million | 471.99 Million | 453.46 Million |
| Operating Income | 56.9 Million | 51.85 Million | 256.23 Million | 97.59 Million | 15.53 Million | -7.57 Million |
| Interest Expense | 17.04 Million | 3.54 Million | 1.33 Million | 10.93 Million | 16.56 Million | 3.94 Million |
| Income Tax Expense | 12.12 Million | 12.26 Million | 76.49 Million | 26.26 Million | -10.42 Million | 820 Thousand |
| Earnings before Tax | 36.36 Million | 48.31 Million | 254.9 Million | 86.65 Million | 30.89 Million | -9.7 Million |
| Net Income | 23.93 Million | 35.9 Million | 178.24 Million | 60.37 Million | 41.25 Million | -10.52 Million |
| Earnings Per Share Basic | 0.12 | 0.18 | 0.89 | 0.40 | 0.20 | -0.05 |
| Earnings Per Share Diluted | 0.12 | 0.18 | 0.88 | 0.40 | 0.20 | -0.05 |
| Weighted Average Shares Outstanding | 198.9 Million | 200.56 Million | 201.29 Million | 152.1 Million | 202.3 Million | 202.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 199.47 Million | 201.11 Million | 201.48 Million | 152.1 Million | 202.3 Million | 202.3 Million |
| Gross Margin | 0.36 | 0.82 | 0.79 | 0.81 | 0.17 | 0.30 |
| EBIT Margin | 0.26 | 0.25 | 0.37 | 0.29 | 0.19 | 0.01 |
| Profit Margin | 0.03 | 0.05 | 0.18 | 0.09 | 0.08 | -0.02 |
| EBITDA | 181.83 Million | 184.93 Million | 372.74 Million | 196.67 Million | 116.3 Million | 3.92 Million |
| Earnings Before Tax Margin | 0.08 | 0.07 | 0.26 | 0.15 | 0.03 | -0.02 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 179.55 Million | 689.72 Million | 179.55 Million | 333.71 Million | 168.63 Million | 336.76 Million |
| Cost of Revenue | 111.5 Million | 551.27 Million | 111.5 Million | 273.29 Million | 109.67 Million | 266.01 Million |
| Gross Profit | 68.04 Million | 138.45 Million | 68.04 Million | 60.42 Million | 58.95 Million | 70.74 Million |
| Operating Expenses | 39.95 Million | 81.54 Million | - | 41.59 Million | 50.98 Million | 48.57 Million |
| Selling, General and Administrative Expenses | 42.62 Million | - | - | 44.56 Million | - | 48.57 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 2.67 Million | 5.64 Million | - | 2.96 Million | - | - |
| Cost and Expenses | 111.5 Million | 632.82 Million | 111.5 Million | 314.89 Million | 160.66 Million | 314.59 Million |
| Operating Income | 68.04 Million | 56.9 Million | 68.04 Million | 18.82 Million | 11.71 Million | 22.16 Million |
| Interest Expense | 8.73 Million | 17.04 Million | - | 8.3 Million | - | 7.53 Million |
| Income Tax Expense | 4.69 Million | 12.12 Million | 4.69 Million | 2.73 Million | 1.36 Million | 4.99 Million |
| Earnings before Tax | 14.28 Million | 36.36 Million | 14.28 Million | 7.8 Million | 3.9 Million | 15.55 Million |
| Net Income | 9.49 Million | 23.93 Million | 9.49 Million | 4.95 Million | 2.47 Million | 10.48 Million |
| Earnings Per Share Basic | 0.05 | - | 0.05 | 0.02 | 0.01 | 0.05 |
| Earnings Per Share Diluted | 0.05 | - | 0.05 | 0.02 | 0.01 | 0.05 |
| Weighted Average Shares Outstanding | 197.59 Million | 198.9 Million | 197.59 Million | 200.5 Million | 201.3 Million | 200.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 197.61 Million | 199.47 Million | 197.61 Million | 201.33 Million | 201.33 Million | 201.37 Million |
| Gross Margin | 0.38 | 0.20 | 0.38 | 0.18 | 0.35 | 0.21 |
| EBIT Margin | 0.13 | - | 0.13 | 0.25 | 0.09 | 0.25 |
| Profit Margin | 0.05 | 0.03 | 0.05 | 0.01 | 0.01 | 0.03 |
| EBITDA | 22.91 Million | - | 22.91 Million | 82.52 Million | 15.24 Million | 84.06 Million |
| Earnings Before Tax Margin | 0.38 | 0.08 | 0.38 | 0.06 | 0.07 | 0.07 |
BRBR
4162
1448
RSRV
XP
BPHLF